ATXI [NASD]
Avenue Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.22 Insider Own5.90% Shs Outstand18.25M Perf Week-1.60%
Market Cap6.66M Forward P/E- EPS next Y-0.19 Insider Trans0.00% Shs Float11.54M Perf Month-34.14%
Income-3.70M PEG- EPS next Q-0.05 Inst Own10.80% Short Float0.72% Perf Quarter-0.03%
Sales- P/S- EPS this Y29.70% Inst Trans-0.48% Short Ratio0.02 Perf Half Y-77.16%
Book/sh0.19 P/B1.65 EPS next Y13.60% ROA-191.80% Target Price- Perf Year-92.81%
Cash/sh0.18 P/C1.75 EPS next 5Y- ROE-276.00% 52W Range0.20 - 5.18 Perf YTD-65.54%
Dividend- P/FCF- EPS past 5Y10.40% ROI- 52W High-93.97% Beta1.05
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low56.45% ATR0.05
Employees4 Current Ratio7.80 Sales Q/Q- Oper. Margin- RSI (14)35.09 Volatility12.70% 14.22%
OptionableNo Debt/Eq0.00 EPS Q/Q16.60% Profit Margin- Rel Volume0.01 Prev Close0.34
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume5.05M Price0.31
Recom3.00 SMA20-17.63% SMA50-36.64% SMA200-69.96% Volume65,841 Change-7.40%
Mar-31-22 07:30AM  
Feb-16-22 08:20AM  
Feb-15-22 10:00PM  
07:05AM  
Dec-15-21 02:15PM  
12:00PM  
Dec-12-21 08:00PM  
Nov-29-21 08:00AM  
Nov-17-21 09:30AM  
Nov-12-21 10:40AM  
09:20AM  
Nov-09-21 09:30PM  
Oct-25-21 07:00AM  
Aug-26-21 11:04AM  
Jun-21-21 08:04AM  
Jun-14-21 08:42AM  
07:44AM  
07:00AM  
Apr-26-21 08:09AM  
Apr-23-21 11:36PM  
09:43AM  
08:41AM  
Apr-22-21 10:59AM  
Apr-21-21 10:34PM  
09:38AM  
Apr-19-21 10:09PM  
06:26AM  
Apr-16-21 11:25PM  
Apr-14-21 10:34PM  
Apr-13-21 11:30PM  
03:09PM  
02:30PM  
09:33AM  
06:30AM  
Apr-12-21 01:36AM  
Jan-11-21 11:32PM  
Jan-06-21 09:23AM  
Dec-18-20 08:00AM  
08:00AM  
Dec-17-20 04:27PM  
07:00AM  
Nov-13-20 05:28AM  
Oct-28-20 07:45PM  
Oct-23-20 10:00PM  
Oct-14-20 08:58PM  
10:10AM  
Oct-13-20 01:29PM  
Oct-12-20 01:35PM  
12:45PM  
10:47AM  
06:30AM  
Sep-09-20 08:00AM  
Aug-17-20 10:33AM  
Aug-14-20 07:30AM  
Aug-04-20 12:53PM  
Jul-28-20 05:50PM  
Jul-22-20 05:50PM  
Jul-21-20 08:30AM  
Jul-16-20 05:50PM  
Jul-09-20 05:50PM  
11:30AM  
Jul-07-20 11:50AM  
Jun-29-20 08:30AM  
Jun-25-20 08:44AM  
Jun-24-20 12:00PM  
11:18AM  
Jun-23-20 10:38AM  
Jun-18-20 10:12AM  
08:50AM  
Jun-17-20 11:30AM  
Jun-16-20 08:37AM  
Jun-15-20 10:00AM  
Jun-11-20 08:55AM  
08:41AM  
Jun-10-20 08:31AM  
Jun-09-20 09:41AM  
Jun-08-20 08:25AM  
Jun-05-20 08:30AM  
May-29-20 11:33AM  
10:31AM  
08:30AM  
May-28-20 09:13AM  
May-27-20 12:43PM  
11:30AM  
09:40AM  
May-26-20 10:44AM  
10:43AM  
08:54AM  
May-22-20 08:42AM  
06:50AM  
May-11-20 07:30AM  
Apr-27-20 09:48AM  
Apr-24-20 11:07AM  
Apr-23-20 09:14AM  
08:30AM  
07:25AM  
Apr-16-20 12:00PM  
Mar-30-20 07:30AM  
Feb-13-20 08:00AM  
Dec-13-19 08:10AM  
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vazzano Joseph WalterChief Financial OfficerSep 15Sale1.627,16011,59965,252Sep 15 04:03 PM